Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma
- DOI
- 10.1158/1078-0432.ccr-23-1317
- Published
- 2023-10-16
- Container
- Clinical Cancer Research
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/1078-0432.ccr-23-1317,
title = {Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma},
author = {Qibiao Wu and Haley Ellis and Giulia Siravegna and Alexa G. Michel and Bryanna L. Norden and Ferran Fece de la Cruz and Eranga Roshan Balasooriya and Yuanli Zhen and Vanessa S. Silveira and Jianwe Che and Ryan B. Corcoran and Nabeel Bardeesy},
year = {2023},
journal = {Clinical Cancer Research},
doi = {10.1158/1078-0432.ccr-23-1317},
url = {https://doi.org/10.1158/1078-0432.ccr-23-1317}
}RIS
TY - JOUR TI - Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma AU - Qibiao Wu AU - Haley Ellis AU - Giulia Siravegna AU - Alexa G. Michel AU - Bryanna L. Norden AU - Ferran Fece de la Cruz AU - Eranga Roshan Balasooriya AU - Yuanli Zhen AU - Vanessa S. Silveira AU - Jianwe Che AU - Ryan B. Corcoran AU - Nabeel Bardeesy PY - 2023 JO - Clinical Cancer Research DO - 10.1158/1078-0432.ccr-23-1317 UR - https://doi.org/10.1158/1078-0432.ccr-23-1317 ER -
APA
Wu, Q., Ellis, H., Siravegna, G., Michel, A. G., Norden, B. L., Cruz, F. F. D. L., Balasooriya, E. R., Zhen, Y., Silveira, V. S., Che, J., Corcoran, R. B., & Bardeesy, N. (2023). Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-23-1317
Source records
- crossref · retrieved 2026-09-26T11:50:41.282Z